eFFECTOR Therapeutics Inc (FRA:LWK)
€ 1.07 -0.005 (-0.47%) Market Cap: 5.14 Mil Enterprise Value: 345,000.00 PE Ratio: 0 PB Ratio: 5.52 GF Score: 21/100

eFFECTOR Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 07:00PM GMT
Release Date Price: €11.8 (-0.42%)
Lucas Olson Duffy
Cantor Fitzgerald - Analyst

Good afternoon, everyone. Today, I'm here with eFFECTOR Therapeutics. My name is Lucas Olson Duffy. I'm a biotech and biopharma, large cap equity research associate on Louise Chen's team here at Cantor. So just to start off a little, could you introduce yourselves and tell us your roles at eFFECTOR?

Mike Byrnes
eFFECTOR Therapeutics, Inc. - CFO

Sure. Mike Byrnes, I'm the Chief Financial Officer at eFFECTOR. Got about 25 years experience in the industry. Joined eFFECTOR about three years ago.

Mayank Gandhi
eFFECTOR Therapeutics, Inc. - Chief Business Officer

Hi. I'm Mayank Gandhi. I'm the Chief Business Officer. Been at eFFECTOR for about a year and been in the industry for about 20 years or so.

Questions & Answers

Lucas Olson Duffy
Cantor Fitzgerald - Analyst

Wow, that's great. Thank you for the introduction. If we could just get straight into it. Can you tell us a little bit about eFFECTOR top-level view, just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot